StockNews.AI
BHC
StockNews.AI
209 days

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

1. Bausch + Lomb to release Q4 and full-year results on February 19, 2025. 2. A conference call will discuss results and provide business updates. 3. The company has a broad portfolio with approximately 400 products. 4. Bausch + Lomb employs around 13,000 people globally, enhancing eye health.

3m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings reports typically result in mixed stock reactions.

How important is it?

The earnings release may influence investor sentiment, but a strong report isn't guaranteed.

Why Short Term?

Immediate reactions expected post-earnings, generally affecting short-term stock price.

Related Companies

BHCBLCO
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial results on Wednesday, February 19, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call. Conference Call Details Date: Wednesday, February 19, 2025 Time: 8 a.m. ET Webcast: https://www.webcaster4.com/Webcast/Page/2883/51712 Participant Event Dial-in: +1 (888) 506-0062 (North America) +1 (973) 528-0011 (International) Participant Access Code: 785090 Replay Dial-in: +1 (877) 481-4010 (North America) +1 (919) 882-2331 (International) Replay Passcode: 51712 (replay available until March 5, 2025) About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram. © 2025 Bausch + Lomb.

Related News